REVISION 17 HIGHLIGHTS New
Discussion of the surgical treatment of spinal stenosis and residual functional capactiy considerations. §1.04.1.b Discussion of artificial lumbar and cervical spinal disk implants. §1.04.2 Discussion of vestibular goggle testing for vestibular disorders with accuracy for Meniere's Disease, BenignParoxysmal Positional Vertigo, and Vestibular Migraine. §2.07.3
Discussion of left vetricular assist devices (LVADs) and why LVAD cases should be allowed as equivalent severityeven if they are not listed as an allowance under heart failure listing 4.02. §4.02.4
Extensive discussion on the evaluation of headaches. §11.02.3 Discussion of benign meningiomas regarding increased aggression of some recurrent tumors and improved methodsmore accurately showing those most likely to be treatment resistant.§11.05.1.a
Discussion of new research indicating cause of autism lies in the peripheral nervous system rather than in the brain.§12.10.3
SLE criteria for 2019. Table 14.02.1.a Discussion of advances in research in regard to increasingly effective treatment of HIV infection. §14.11.aUpdated
Arthroscopic surgery for torn cartilage in knees and its questionable benefits. §1.02.2 Residual problems after total hip or knee replacements and implications for residual functional capacity. §1.03.2 Accepted diagnostic cut-off value for diagnosis of COPD using pulmonary function studies. §3.02.1.a Cause of vaso-occlusive crises. §7.05.1.a Testing for consciousness in pseudoseizures. §11.02.1.a Frequent misdiagnosis of multiple sclerosis. §11.09.3 Causes of and outcomes for Guillain-Barre syndrome. §11.14.1.a Neuronal damage and restriction of blood flow to brain tissue in patients with Alzheimer's disease. §12.01.a Chronic traumatic encephalopathy and single head injury. §12.02.1.a Risk of dementia with SLE compared to other immune disorders. §14.02.3
...read more
